Cerebras IPO Prices at 185 Surpassing ExpectationsA Key Test for AI Infrastructure Demand Provectus Biopharmaceuticals Issues Going Concern Warning Following Q1 2026 Loss Gartner IT Stock Analysis 123 Gain What to Watch 20260514